# Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

> **NCT04367935** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 43 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT04367935
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-04-25
- **Final completion:** 2022-04-25
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367935, "Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04367935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*